Imcyse
Developing active and specific immunotherapies aimed at treating and curing severe chronic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€85—128m (Dealroom.co estimates Feb 2021.)
Company register number 0828.385.542
Liège Liège (HQ)
Authorizing premium user...